chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from an office manager and refers to a 12 month-old patient of unknown gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history reported. On 26-OCT-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with an expiration date on 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. No data logger was involved. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Dizziness, Headache, Myalgia Chills, fatigue Narrative:
Pt received Prevnar vaccine on 8/1/01. On 8/7/01, the pt presented with coughing, low-grade temperature, no diarrhea. Erythema was noted on trunk. Treatment recommended was Benadryl X 2 days and Tylenol prn. Pt was also irritable. (Unable to contact parents).
Headache, Myalgia & Fever Narrative: missed work following second dose due to the above symptoms
Fever, shaking chills >12 hours, drenching sweats, severe myalgias, headache, generalized weakness, fatigue
Rash on Left flank. frequent seizures starting one week after vaccination. Joint pain starting 2 days after vaccination.
Pt notified me for the first time on the morning of 2/18/19, roughly 2 weeks after the shot had been administered. She reported balance disturbances (resulting in several falls) and struggling to "walk straight." She takes several medications that can induce this type of reaction (ie, oxycodone, gabapentin, and VALIUM). I explained to her that it is not a known reaction to the vaccine, but that she should reach out to her doctor due to the fall incidents and potential severity. I also informed her that I would be reporting the reaction via VAERS.
It looks like allergies reactions.; I'm having all kind of breakouts rash since then/These is going on, I have a huge rash in my feet; I got a red rash that went away two days after. I'm having all kind of breakouts rash since then. It looks like allergies reactions. These is going on, I have a huge rash in my feet; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (I got a red rash that went away two days after. I'm having all kind of breakouts rash since then. It looks like allergies reactions. These is going on, I have a huge rash in my feet), HYPERSENSITIVITY (It looks like allergies reactions.) and RASH (I'm having all kind of breakouts rash since then/These is going on, I have a huge rash in my feet) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Ankle operation (Ankle transplant).   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (I got a red rash that went away two days after. I'm having all kind of breakouts rash since then. It looks like allergies reactions. These is going on, I have a huge rash in my feet), HYPERSENSITIVITY (It looks like allergies reactions.) and RASH (I'm having all kind of breakouts rash since then/These is going on, I have a huge rash in my feet). At the time of the report, RASH ERYTHEMATOUS (I got a red rash that went away two days after. I'm having all kind of breakouts rash since then. It looks like allergies reactions. These is going on, I have a huge rash in my feet) had resolved and HYPERSENSITIVITY (It looks like allergies reactions.) and RASH (I'm having all kind of breakouts rash since then/These is going on, I have a huge rash in my feet) outcome was unknown.            Patient current medical history include Blood pressure. Concomitant medications include Blood pressure pills. Treatment medications include antibiotics for Rash.
The second menstrual period in 14 days.  Already had a regular monthly cycle Sept 1-5.  On September 15 (2 days after the second Moderna shot), another period began and it is now day 5 with no signs of stopping.
On 11/7/08, had 2 lesions on right thigh, 1 left ankle, 1 upper arm and 2 on chest.  MD prescribed Valtrex and lesions dried within 48 hours.  Labs show Varicella IGG and IGM both negative on 11/7/08.
Generalized joint pain, red pin point rash on legs, swollen glands, sore throat, ongoing low grade fever.
apneic episode 56hr p/vax felt to be secondary to GE reflux;found blue & quiet;mom started CPR-spit up & responded p/<1min;hosp;PH probe positive;
Bright red rash on her midriff; Pink rash on her breast and thighs; Slight nausea; Slight headache; This spontaneous case was reported by a nurse and describes the occurrence of RASH ERYTHEMATOUS (Bright red rash on her midriff), RASH (Pink rash on her breast and thighs), NAUSEA (Slight nausea) and HEADACHE (Slight headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Allergy to Coffee, soda, sugar and alcohol), Osteopenia since 28-Jan-2011, Vitamin D deficiency since 05-Sep-2019, Basal cell carcinoma since 02-Feb-2013 and Adhesive tape allergy. Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HCTZ) from 28-Jan-2011 to an unknown date for Calcium abnormal NOS, CALCIUM, COLECALCIFEROL (CALCIUM WITH D3) for Osteopenia, VITAMIN D [VITAMIN D NOS] from 05-Sep-2014 to an unknown date for Vitamin D deficiency, MULTIVITAMIN [VITAMINS NOS] and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 10-Feb-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Bright red rash on her midriff) and RASH (Pink rash on her breast and thighs). 11-Mar-2021, the patient experienced NAUSEA (Slight nausea) and HEADACHE (Slight headache). On 11-Mar-2021, NAUSEA (Slight nausea) and HEADACHE (Slight headache) had resolved. On 13-Mar-2021, RASH ERYTHEMATOUS (Bright red rash on her midriff) and RASH (Pink rash on her breast and thighs) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered RASH ERYTHEMATOUS (Bright red rash on her midriff), RASH (Pink rash on her breast and thighs), NAUSEA (Slight nausea) and HEADACHE (Slight headache) to be probably related.    No concomitant medicines were reported. Treatment information included Benadryl 30 minutes prior to second dose.  Action taken with the drug in response to events were not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Additional information received.  Updated reporter details, patient initials.  Patient mentioned that he has never been diagnosed with COVID-19.  Added Other Relevant History, concomitant medication.  Patient mentioned that there was no itching from the rash.  Start date of the events rash erythematous and rash was changed from 11 March 2021 to 12 March 2021 and the stop dates of these events were added.
Stuffy nose; Cough; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose) and COUGH (Cough) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (Stuffy nose) and COUGH (Cough). At the time of the report, NASAL CONGESTION (Stuffy nose) and COUGH (Cough) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jun-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Itchy feet, hands, arms, mouth.  Throat began to feel tight.  Eyelids began to itch.
Patient is fully vaccinated. COVID + on 12/5/2021.  Patient hospitalized for 15 days starting 12/2/2021.  Patient is a known case of high blood pressure coronary artery disease who presented to the hospital acute respiratory failure related to COVID pneumonia. Treated with IV steroids and IV remdesivir.  The patient condition continued to deteriorate.  Family opted for the patient to be transitioned to hospice care and comfort care and patient started on IV morphine drip and IV Ativan and patient expired.
Vasovagal syncope starting at 10 hours post vaccination- lightheadedness, fainting, urge to vomit upon standing. Resolved by laying back down and not standing up.
This spontaneous case was reported by a pharmacist and describes the occurrence of NO ADVERSE EVENT (The patients have not reported any adverse reactions), TRANSCRIPTION MEDICATION ERROR (Cards reflects the wrong lot numbers and we can not figure out which patient's records are wrong.) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     No Medical History information was reported.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (The patients have not reported any adverse reactions) to be not related. No further causality assessments were provided for TRANSCRIPTION MEDICATION ERROR (Cards reflects the wrong lot numbers and we can not figure out which patient's records are wrong.) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error).    No relevant concomitant medications were reported.  The patients have not reported any adverse reactions. No treatment information was provided.
Patient initially described typical arm soreness that is known to occur with Covid 19 vaccinations.  By the weekend he was having difficulty raising arm and that has continued to date. Patient can raise raise left arm all directions except for forwards in front of his body.
after getting the vaccine, his mind started to feel foggy, he has felt like walking in a trampoline; Couldn't sleep; This spontaneous case was reported by a patient and describes the occurrence of BRAIN FOG (after getting the vaccine, his mind started to feel foggy, he has felt like walking in a trampoline) in a male patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Patient had participated in a Moderna RSV study 2 years ago. Patient was non Moderna clinical trial participant.     On an unknown date, the patient received third dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced BRAIN FOG (after getting the vaccine, his mind started to feel foggy, he has felt like walking in a trampoline) (seriousness criterion medically significant) and INSOMNIA (Couldn't sleep). At the time of the report, BRAIN FOG (after getting the vaccine, his mind started to feel foggy, he has felt like walking in a trampoline) and INSOMNIA (Couldn't sleep) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided.  Patient confirmed that the side effects which the patient experienced were not during the time when the patient was in the study but happened during the time when the patient received the third dose of Moderna COVID-19 vaccine. Reported that patient got disabled after getting the Moderna Vaccine.  Treatment information was not reported.  Company comment- This is a spontaneous case concerning a male patient of unknown age with no medical history reported who experienced the unexpected and serious (medically significant) event brain fog. A dose of Spikevax (COVID19 Vaccine, mRNA) 2023-2024 Formula, given as a third dose of COVID vaccine schedule, was administered. It was reported patient got disabled after getting the Moderna vaccine, his mind started to feel foggy, he felt like walking in a trampoline and couldn't sleep. The benefit-risk relationship of Spikevax (COVID19 Vaccine, mRNA) 2023-2024 Formula is not affected by this report.
Headache, Myalgia, Diarrhea, NauseaVomiting,  chills, sweats  Narrative:  1/9 employee woke up with a headache, chills and nausea. He threw  up and felt better. Then he had sweats and diarrhea. He threw up 4 times  throughout the day until about 3:00 in the afternoon. He called in sick for work. He  also had minor aches and pains. He felt better on Sunday though he still had  headache, body aches, sweats, and diarrhea. All symptoms resolved as of 1/11.  He took tylenol and Nyquil which helped.
Two weeks after vaccine, I the injection site has turned red with some heat. And beginning this morning I have a sore throat, fatigue, joint pain, congestion, some cough and generally do not feel well.
Onset 8/3/2010. (R) thigh, 10 cm lesion (erythema). Ibuprofen or TYLENOL as needed, cold compresses..
reaction 5 mins after shot. large welt came up and it was red; reaction 5 mins after shot. large welt came up and it was red; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case was linked to 2019SA271041 (same reporter).  This case involves a 30 years old female patient who experienced large welt came up (urticarial) and it was red (erythema), while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No concomitant medication received.  On 24-Sep-2019, the patient received a single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported in the left deltoid.  On an unknown date, The patient developed a non-serious large welt came up and it was red (urticaria) (erythema) 5 minutes following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  No lab test reported. . Final diagnosis was reaction large welt came up and it was red.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for the events.  Information on the batch number was requested.
19JUL97 had fever 105 gave motrin that evening 106.2 & had convuls;20JUL97 called MD & instructed to give motrin & APAP but fever was sl that day;21JUL97 OK;
Within about 5-10 min felt nauseated and dizzy fainted and fell on the floor at Dr. office. Ambulance came took her to Hospital. (Did blood work and CT of head and back).
My arm was sore for about two days after the vaccination. The soreness went away but then returned after about a week. When it came back it was extremely sore for another 3 days. I do have a history of rotator cuff injury which I feel made the soreness worse. I was not able to get my elbow up past my waist. I did go visit the doctor and she advised I had a lipoma. After about 16 days the pain went way.
Fatiga extrema, fiebre muy alta, escalofríos, nodulo debajo del brazo izquierdo, migraña, dolor de cabeza.
Patient was administered Pfizer COVID-19 vaccine in store. Roughly five minutes later, he felt slightly lightheaded and collapsed in an aisle of the store. Pharmacist attended to the patient. He did not recall falling. He was observed to have a bruised nose and a small laceration on the lip. Patient's pulse and blood pressure were regular. Store manager provided water and an icepack. Patient continued to be monitored in store for an additional 20 minutes, after which time he stated he felt fine, and left with his mother. Patient had no history of reaction to immunizations.
she only had injection site pain after vaccine first dose; This is a spontaneous report received from a non-contactable other consumer (Patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in left arm on 14Mar2021 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received the first dose on 14Mar2021. She only had injection site pain after vaccine first dose. Event outcome was unknown.  No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.
Intense itching of hands and randomly on other parts of body.  Red rashes.  Occurred only at night and disappeared in the morning.
This is a spontaneous report by a contactable physician through a Pfizer sales representative on behalf of a currently 7-month-old patient who was administered with PREVNAR13 single dose on unknown date for immunisation. Relevant medical history and concomitant medications were unknown. On unknown date, the patient experienced meningitis that required hospitalization. Relevant lab data was unknown. At the time of report the patient was recovering from the event.
On June 6, 2022 I received the first of two injections for Shingles.   OnJuly 25, 2022, I felt the first sign of itching, burning and stinging above my left eye lid. On July 26, 2022 I went to the walk in clinic. Severe pain on face, eye, neck and arms. July 27, 2022, I met with my eye physician, Dr. Shyngles was not in my eye. July 28, 2022 I drove to the ER. Vicious pain, itching, swelling and stinging all over my head, neck and right arm.
ITCHY AND BLISTER ON FOOT ON THE FIRST DAY TOOK BENADRYL AND BETTER THE NEXT DAY.
No adverse event reported. Pt was given 0.2 ml Pfizer Covid Bivalent Peds 5 -11 years instead of 0.2 ml Pfizer Primary Covid Peds 5-11 years. They got the Bivalent Booster instead of the primary #2 in series.
myalgia; fever; shivering; headache; fatigue; gastrointestinal symptoms; This case was reported by a consumer and described the occurrence of myalgia in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th August 2021 09:30, the patient received the 2nd dose of Shingrix. On 26th August 2021 09:00, 11 hrs 30 min after receiving Shingrix, the patient experienced myalgia, fever, shivering, headache, fatigue and gastrointestinal disorder. On an unknown date, the outcome of the myalgia, fever, shivering, headache, fatigue and gastrointestinal disorder were not recovered/not resolved.   It was unknown if the reporter considered the myalgia, fever, shivering, headache, fatigue and gastrointestinal disorder to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient himself. The patient received second dose of Shingrix at 9:30 am and experienced myalgia, fever, headache, shivering, fatigue and gastrointestinal symptoms. All symptoms began around 9:00pm, the same day and were ongoing till the time of reporting. The reporter did not consent to follow-up.
Pt noticed body aches/headaches, (30 min. later) nauseated, plus conjunctivitis (3 hrs. later) on both eyes. Pt took BENADRYL every 4 hours x 24. She is okay today.
Arm pain; Fatigue; A spontaneous report was received from a consumer concerning a male patient of unspecified age, who received Moderna's COVID-19 vaccination (mRNA-1273) and experienced arm pain and fatigue after vaccination.  The patient's medical history included heart arrhythmia PVC and he took a beer on the same of vaccination. No concomitant medications were reported.  On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in arm for prophylaxis of COVID-19 infection.   On 30 Dec 2020, the patient experienced arm pain from the vaccination and fatigue. No treatment information was provided.  Action taken with mRNA-1273 vaccine was not provided.  The outcome of the events, pain in the arm and fatigue was reported as not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Immediate, intense lightheadedness, faint-feeling, abnormally high blood pressure; nurses immediately laid me down. I continued feeling this way and my blood pressure remained abnormally high (145/120) for 45 minutes. After one hour of observation I was able to leave the doctor's office.
Pt given HPV vaccine and left exam room to lobby with parent.  LOC at check out counter.  No injury noted.
At checkout patient had a vasovagal episode and passed out.  No trauma was noted.  She may have lost consciousness for a few seconds but awoke immediately upon falling on the ground.  She was placed in a exam room and was hemodynamically stable.  No trauma noted.  Most likely this was a vasovagal episode due to getting her flu and shingles vaccine.  She was observed for 10 minutes with normal hemodynamics and felt well.  Random blood sugar was 107.
Breakthrough case admission after two vaccines Moderna 6/15/21 Lot# 054C21A;  Moderna 7/14/21 LOt# 028D
2 days after mom notified us by phone - came in that pt had a rash where the sites of the vaccine P. Iz (L) thigh fine maculopapular rash surrounded the area with the shot.